Odyssey Health (ODYY) Net Margin (2014 - 2016)

Odyssey Health (ODYY) reported Net Margin of 246.36% for Q3 2016, down 577.3% sequentially from 36.37% in Q2 2016.

Odyssey Health (ODYY) Net Margin (2014 - 2016) Analysis & Trends

Odyssey Health has disclosed Net Margin across 3 years of filings, most recently posting 246.36% for Q3 2016.

  • Quarterly Net Margin changed N/A year-over-year to 246.36% in Q3 2016, while the trailing twelve-month figure through Apr 2017 was 1136.24% (down 81028.0% YoY) and the FY2016 annual result came in at 229.94%, down 16746.0% from the prior year.
  • Net Margin slipped to 246.36% in Q3 2016, from 36.37% in the prior quarter.
  • Across five years, Net Margin topped out at 31.44% in Q4 2014 and bottomed at 246.36% in Q3 2016.
  • The 3-year median for Net Margin is 50.2% (2015), against an average of 120.09%.
  • The widest YoY moves for Net Margin: up 19972 bps in 2016, down 19972 bps in 2016.
  • Odyssey Health's Net Margin stood at 31.44% in 2014, then sank by 651 bps to 236.09% in 2015, then decreased by 4 bps to 246.36% in 2016.
  • According to Business Quant data, Net Margin over the past three periods registered 246.36%, 36.37%, and 236.09% for Q3 2016, Q2 2016, and Q2 2015 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin (Qtr)
1 Abbott Laboratories 154.42 Bn 147.76 Bn 6.27 Bn 9.65%
2 Stryker 118.12 Bn 115.25 Bn 3.81 Bn 12.38%
3 Medtronic 101.72 Bn 93.55 Bn 5.76 Bn 12.75%
4 Boston Scientific 67.19 Bn 65.98 Bn 3.61 Bn 25.77%
5 Edwards Lifesciences 50.69 Bn 47.02 Bn 1.29 Bn -
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 0.00%
7 Dexcom 28.09 Bn 26.97 Bn 750.30 Mn 16.74%
8 GE HealthCare Technologies 28.08 Bn 26.02 Bn 1.98 Bn 8.01%
9 Steris 19.80 Bn 19.37 Bn 697.10 Mn -
10 Odyssey Health - - - -

Historic Data

Download Data
DateValue
Jul 31, 2016 -246.36%
Apr 30, 2016 -36.37%
Apr 30, 2015 -236.09%
Jan 31, 2015 -50.20%
Oct 31, 2014 -31.44%